0000899243-22-014962.txt : 20220418
0000899243-22-014962.hdr.sgml : 20220418
20220418160519
ACCESSION NUMBER: 0000899243-22-014962
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220414
FILED AS OF DATE: 20220418
DATE AS OF CHANGE: 20220418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Yuchun
CENTRAL INDEX KEY: 0001334365
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 22832185
MAIL ADDRESS:
STREET 1: 170 TRACER LA.
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-14
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001334365
Lee Yuchun
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2022-04-14
4
M
0
2000
81.54
A
3875
D
Common Stock
2022-04-14
4
S
0
948
287.87
D
2927
D
Common Stock
2022-04-14
4
S
0
252
288.92
D
2675
D
Common Stock
2022-04-14
4
S
0
400
289.84
D
2275
D
Common Stock
2022-04-14
4
S
0
400
291.18
D
1875
D
Stock Option (Right to Buy)
81.54
2022-04-14
4
M
0
2000
0.00
D
2023-05-31
Common Stock
2000
2000
D
Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $287.87 (range $287.49 to $288.26).
Open market sales reported on this line occurred at a weighted average price of $288.92 (range $288.51 to $289.24).
Open market sales reported on this line occurred at a weighted average price of $289.84 (range $289.69 to $289.96).
Open market sales reported on this line occurred at a weighted average price of $291.18 (range $290.80 to $291.64).
Fully vested.
/s/ Sabrina Yohai, Attorney-in-Fact
2022-04-18